FDA Drug/Biologics Approval BLA 125166 S-422, ECULIZUMAB

FDA Drug/Biologics Approval BLA 125166 S-422, ECULIZUMAB

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125166 S-422
Company: ALEXION PHARM
Drug Name: SOLIRIS
Active Ingredients: ECULIZUMAB
Strength: 300MG
Dosage Form/Route: INJECTABLE; IV (INFUSION)
Action Date: 03/16/2007
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details